Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

215 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Higher 1-year mortality on rest days in patients with acute coronary syndromes and decompensated heart failure-A SPUM-ACS sub-study.
Matter MA, Candreva A, Stähli BE, Heg D, Klingenberg R, Räber L, Windecker S, Rodondi N, Nanchen D, Mach F, Gencer B, Ruschitzka F, Matter CM, Templin C. Matter MA, et al. Among authors: matter cm. Catheter Cardiovasc Interv. 2024 Feb;103(2):286-294. doi: 10.1002/ccd.30938. Epub 2023 Dec 25. Catheter Cardiovasc Interv. 2024. PMID: 38145467
PARP1 is required for adhesion molecule expression in atherogenesis.
von Lukowicz T, Hassa PO, Lohmann C, Borén J, Braunersreuther V, Mach F, Odermatt B, Gersbach M, Camici GG, Stähli BE, Tanner FC, Hottiger MO, Lüscher TF, Matter CM. von Lukowicz T, et al. Among authors: matter cm. Cardiovasc Res. 2008 Apr 1;78(1):158-66. doi: 10.1093/cvr/cvm110. Epub 2007 Dec 18. Cardiovasc Res. 2008. PMID: 18093987 Free article.
Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease.
Besler C, Heinrich K, Rohrer L, Doerries C, Riwanto M, Shih DM, Chroni A, Yonekawa K, Stein S, Schaefer N, Mueller M, Akhmedov A, Daniil G, Manes C, Templin C, Wyss C, Maier W, Tanner FC, Matter CM, Corti R, Furlong C, Lusis AJ, von Eckardstein A, Fogelman AM, Lüscher TF, Landmesser U. Besler C, et al. Among authors: matter cm. J Clin Invest. 2011 Jul;121(7):2693-708. doi: 10.1172/JCI42946. Epub 2011 Jun 23. J Clin Invest. 2011. PMID: 21701070 Free PMC article.
Comparison of biolimus eluted from an erodible stent coating with bare metal stents in acute ST-elevation myocardial infarction (COMFORTABLE AMI trial): rationale and design.
Räber L, Kelbaek H, Ostoijc M, Baumbach A, Tüller D, von Birgelen C, Roffi M, Pedrazzini G, Kornowski R, Weber K, Heg D, Matter C, Lüscher T, Taniwaki M, Meier B, Jüni P, Windecker S. Räber L, et al. EuroIntervention. 2012 Apr;7(12):1435-43. doi: 10.4244/EIJV7I12A224. EuroIntervention. 2012. PMID: 22301368 Free article. Clinical Trial.
Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial.
Räber L, Kelbæk H, Ostojic M, Baumbach A, Heg D, Tüller D, von Birgelen C, Roffi M, Moschovitis A, Khattab AA, Wenaweser P, Bonvini R, Pedrazzini G, Kornowski R, Weber K, Trelle S, Lüscher TF, Taniwaki M, Matter CM, Meier B, Jüni P, Windecker S; COMFORTABLE AMI Trial Investigators. Räber L, et al. Among authors: matter cm. JAMA. 2012 Aug 22;308(8):777-87. doi: 10.1001/jama.2012.10065. JAMA. 2012. PMID: 22910755 Clinical Trial.
Antibody phage display assisted identification of junction plakoglobin as a potential biomarker for atherosclerosis.
Cooksley-Decasper S, Reiser H, Thommen DS, Biedermann B, Neidhart M, Gawinecka J, Cathomas G, Franzeck FC, Wyss C, Klingenberg R, Nanni P, Roschitzki B, Matter C, Wolint P, Emmert MY, Husmann M, Amann-Vesti B, Maier W, Gay S, Lüscher TF, von Eckardstein A, Hof D. Cooksley-Decasper S, et al. PLoS One. 2012;7(10):e47985. doi: 10.1371/journal.pone.0047985. Epub 2012 Oct 24. PLoS One. 2012. PMID: 23110151 Free PMC article.
Prospective, multicenter validation of prediction scores for major bleeding in elderly patients with venous thromboembolism.
Scherz N, Méan M, Limacher A, Righini M, Jaeger K, Beer HJ, Frauchiger B, Osterwalder J, Kucher N, Matter CM, Banyai M, Angelillo-Scherrer A, Lämmle B, Husmann M, Egloff M, Aschwanden M, Bounameaux H, Cornuz J, Rodondi N, Aujesky D. Scherz N, et al. Among authors: matter cm. J Thromb Haemost. 2013 Mar;11(3):435-43. doi: 10.1111/jth.12111. J Thromb Haemost. 2013. PMID: 23279158 Free article.
The Swiss cohort of elderly patients with venous thromboembolism (SWITCO65+): rationale and methodology.
Méan M, Righini M, Jaeger K, Beer HJ, Frauchiger B, Osterwalder J, Kucher N, Lämmle B, Cornuz J, Angelillo-Scherrer A, Rodondi N, Limacher A, Trelle S, Matter CM, Husmann M, Banyai M, Aschwanden M, Egloff M, Mazzolai L, Hugli O, Bounameaux H, Aujesky D. Méan M, et al. Among authors: matter cm. J Thromb Thrombolysis. 2013 Nov;36(4):475-83. doi: 10.1007/s11239-013-0875-2. J Thromb Thrombolysis. 2013. PMID: 23359097 Free article. Clinical Trial.
215 results